Gabapin Nt 200 Tab
Marketer
Intas Pharmaceuticals Ltd
Composition
Gabapentin (200mg) + Nortriptyline (10mg)
About Gabapin Nt 200 Tab
Gabapin Nt 200 Tab (Gabapentin + Nortriptyline) is a combination often prescribed for managing chronic neuropathic pain and depression when other treatments haven't been fully effective. This combination medication works by impacting neurotransmitters in the brain and nervous system to reduce pain signals and improve mood. However, it's crucial to understand the potential side effects, like drowsiness and dizziness, and to carefully follow your doctor's instructions regarding dosage and safety precautions. Alcohol should be avoided, and driving or operating machinery should be done with caution. Consult your doctor immediately if you experience any unexpected or concerning side effects.
Last Updated On 22 May. 2025 | 02:29 PM (IST)
Report Error
Was this Product Information helpful?
Some people found this information helpful
User Feedback
Disclaimer
We, at MedCart make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed
medicine-related information to our consumers. However, it should, by no means, be considered a
substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship.
In fact, we detest any form of self-medication without expert advice. The sole purpose of the
information on our portal is to educate our consumers, which helps improve the communication
between a doctor and a patient. The information by no means is complete in its entirety and
should not be used to diagnose or treat any medical condition. No amount of information can
replace the experience and expertise of a doctor, therefore his/her advice always holds
priority and should be followed appropriately.

5k+ people saw this product recently
MRP
₹286.50
10% off applied
In Stock
₹257.85
(₹17.19 per unit)
For 15 Tablet (s)
Inclusive of all Taxes
Delivery Pincode
Check
Delivery in 60-90 mins
Cash on Delivery Available
Easy 7 Days Return Available
Expires on or after Dec 2024
Country of Origin: India
User Feedback